Handling Oxygenation Targets in COVID-19

PHASE4CompletedINTERVENTIONAL
Enrollment

726

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

March 8, 2023

Study Completion Date

March 8, 2024

Conditions
Hypoxemic Respiratory FailureOxygen Toxicity
Interventions
DRUG

Low oxygenation target

Oxygen administration to achieve a PaO2 of 8 kPa (60 mmHg) from ICU admission to ICU discharge

DRUG

High oxygenation target

Oxygen administration to achieve a PaO2 of 12 kPa (90 mmHg) from ICU admission to ICU discharge

Trial Locations (10)

2100

Dept. of Intensive Care 4131, Copenhagen University Hospital Rigshospitalet, Copenhagen

2730

Dept. of Intensive Care, Herlev Hospital, Herlev

3400

Dept. of Intensive Care, Hillerød Hospital, Hillerød

4031

Universitätsspital Basel, Basel

4200

Dept. of Intensive Care, Slagelse Hospital, Slagelse

4600

Dept. of Intensive Care, Køge Hospital, Køge

6000

Dept. of Intensive Care, Kolding Hospital, Kolding

8930

Randers Hospital, Randers

9000

Dept. of Intensive Care, Aalborg University Hospital, Aalborg

Unknown

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Copenhagen Trial Unit, Center for Clinical Intervention Research

OTHER

lead

Aalborg University Hospital

OTHER

NCT04425031 - Handling Oxygenation Targets in COVID-19 | Biotech Hunter | Biotech Hunter